-
Bharat Biotech commences human trial of COVAXIN at PGI Rohtak
expresspharma
July 20, 2020
The human trial of Bharat Biotech’s COVID-19 vaccine Covaxin began at Rohtak’s Post-Graduate Institute of Medical Sciences, informed Anil Vij, Health Minister of Haryana through a tweet.
-
Zydus Cadila plans to complete trials of COVID-19 vaccine by March
expresspharma
July 20, 2020
Early-stage Phase 1 and 2 human trials are likely to be concluded in the next three months.
-
Gavi announces 75 countries intend to join COVAX access facility
pharmaceutical-technology
July 17, 2020
Gavi, The Vaccine Alliance, has said that 75 countries have expressed interest to join the COVAX access facility intended to ensure fast and equitable access to Covid-19 vaccines globally.
-
Russian scientists hail results of COVID-19 vaccine trial
expresspharma
July 17, 2020
Speaking to a crowded room without wearing masks, three of 18 volunteers monitored over a month at the Sechenov University said they all had experienced few side-effects.
-
Indian pharma industry can produce COVID-19 vaccines for entire world: Bill Gates
expresspharma
July 17, 2020
Highlighting Gates Foundation's role in India’s war against coronavirus, he said that it has been funding work on detection and isolation, especially in UP and Bihar.
-
J&J in talks with Japan, Gates Foundation to lock in deals on COVID-19 vaccine
expresspharma
July 17, 2020
J&J has already agreed to prioritize an allocation to the United States as part of its funding agreement with the U.S. government’s Biomedical Advanced Research and Development Authority.
-
7 Hills Pharma Announces Positive Data with Oral Immunostimulant to Improve Effectiveness of COVID-19 Vaccines
americanpharmaceuticalreview
July 16, 2020
7 Hills Pharma announced preclinical studies reveal 7HP349, an oral integrin activator that promotes cell adhesion, significantly increases IgG binding antibodies with a vaccine targeting SARS-CoV-2 (COV2), the virus that causes COVID-19.
-
Experimental COVID-19 vaccine mRNA-1273 is safe and elicits response
europeanpharmaceuticalreview
July 16, 2020
Interim analysis of the Phase I trial data from 45 patients indicates mRNA-1273 can drive the production of antibodies targeting the SARS-CoV-2 spike protein.
-
COVID-19 vaccine candidate gets green light for trial in China
europeanpharmaceuticalreview
July 16, 2020
The COVID-19 vaccine candidate, BNT162b1, has been approved for clinical trial registration by China’s National Medical Products Administration (NMPA).
-
AstraZeneca ties up with IQVIA to speed up studies of COVID-19 vaccine candidate
expresspharma
July 16, 2020
The collaboration is part of the US government’s Operation Warp Speed to accelerate the development of COVID-19 vaccines and treatments.